South Africa's iDexis appeals court ruling over compounded weight-loss drugs
South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production ‌of compounded weight-loss medicines, disputing allegations about product ...
Invezz
Hims & Hers stock jumps as Canaccord lifts target ahead of FDA review
Buy HIMS. The stock is already showing accelerating fundamentals (33% LTM revenue growth, 73% gross margin) plus credible weight-loss distribution via Novo Nordisk’s largest telehealth partner. The ...
Hosted on MSN
Hims & Hers stock surges as analysts lift price targets
Hims & Hers Health Inc HIMS shares are rising on Wednesday after BofA Securities and Canaccord Genuity raised their respective price targets on the stock. Canaccord Genuity analyst Maria Ripps kept a ...
Reuters
Hims' obesity drug business may get boost as employers drop coverage
NEW YORK, June 25 (Reuters) - Telehealth provider Hims & Hers Health (HIMS.N), opens new tab may get a boost next year from employers dropping coverage of weight-loss drugs like Novo Nordisk's ...
TechRepublic
Ozempic Maker Novo Nordisk Confirms Security Incident After $25M Hacker Demand
Hackers claim they stole 1.3TB of Novo Nordisk data, including clinical trial and AI model information, after issuing a $25 million demand. A claimed breach at Novo Nordisk is putting more than ...
Barron's
Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market
That buzzy peptide market that Hims & Hers wants in on could be worth close to $2.2 billion next year for the telehealth industry, according to a new estimate. And the amount for Hims & Hers: $440 ...
Bleeping Computer
Pharma giant Novo Nordisk discloses breach of clinical trials data
Danish pharmaceutical giant Novo Nordisk, the world's largest producer of insulin, disclosed a data breach affecting patient information from some clinical trials. Founded in 1923, Novo Nordisk now ...
Business Wire
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the expansion of Hims & Hers Benefits, adding eight new partners to the ...
The Washington Post
Hims & Hers CEO is plotting new ways to upend traditional health care
The next phase of Andrew Dudum’s quest to change how Americans get their health care is taking shape behind the walls of a nondescript factory, tucked off a side street in Silicon Valley. As ...
MobiHealthNews
Hims & Hers launches generic semaglutide offering in Canada
Hims & Hers announced it will offer generic semaglutide through its direct-to-consumer virtual care platform to eligible customers in Canada, following Novo Nordisk's loss of Canadian patent ...
Seeking Alpha
Hims & Hers launches generics for Novo’s semaglutide in Canada
Hims & Hers Health (HIMS) on Thursday announced the launch of generic versions of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy semaglutide through its telehealth platform in Canada. The ...